Valiant Laborato

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0JWS01017
  • NSEID: VALIANTLAB
  • BSEID: 543998
INR
61.10
5.81 (10.51%)
BSENSE

Mar 20

BSE+NSE Vol: 6.56 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BDH Industries
Medico Remedies
Zenotech Lab.
Trident Lifeline
Gennex Lab.
Bafna Pharma.
Everest Organics
Valiant Laborato
Solara Active PP
Infinium Pharma
Sat Kartar

Why is Valiant Laboratories Ltd ?

1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.50
  • The company has been able to generate a Return on Equity (avg) of 0.80% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
  • PAT(Q) At Rs -7.06 cr has Fallen at -657.0% (vs previous 4Q average)
  • PBDIT(Q) Lowest at Rs -0.89 cr.
  • OPERATING PROFIT TO NET SALES (Q) Lowest at -1.70%
3
With ROE of 1.6, it has a Expensive valuation with a 1 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -27.13%, its profits have fallen by -4.8%
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -27.13% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Valiant Laborato for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Valiant Laborato
-27.27%
-0.59
46.42%
Sensex
-2.38%
-0.19
12.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-8.24%
EBIT Growth (5y)
-21.33%
EBIT to Interest (avg)
-3.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.68
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
-0.72%
ROE (avg)
0.80%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
31
Price to Book Value
1.05
EV to EBIT
182.69
EV to EBITDA
59.88
EV to Capital Employed
1.05
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.56%
ROE (Latest)
1.60%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(9M)

At Rs 145.48 cr has Grown at 92.46%

-8What is not working for the Company
PAT(Q)

At Rs -7.06 cr has Fallen at -657.0% (vs previous 4Q average

PBDIT(Q)

Lowest at Rs -0.89 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -1.70%

PBT LESS OI(Q)

Lowest at Rs -3.62 cr.

EPS(Q)

Lowest at Rs -1.30

Loading Valuation Snapshot...

Here's what is working for Valiant Laborato

Net Sales - Latest six months
At Rs 98.66 cr has Grown at 73.97%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Valiant Laborato

Profit After Tax (PAT) - Quarterly
At Rs -7.06 cr has Fallen at -657.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.27 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.89 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -1.70%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -3.62 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -1.30
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)